← Back to Search

Single Arm Study for Esophageal Adenocarcinoma (PR-0410 Trial)

N/A

Recruiting

Research Sponsored by Lucid Diagnostics, Inc.

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Timeline

Screening 3 weeks

Treatment Varies

Follow Up through study completion, an average of 1 year

Awards & highlights

PR-0410 Trial Summary

This trial evaluates the use of a test (EsoGuard) & how it affects decisions to refer patients for endoscopy & patient compliance.

Eligible Conditions

Esophageal Adenocarcinoma
Barrett's Esophagus

PR-0410 Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ through study completion, an average of 1 year

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~through study completion, an average of 1 year

This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Clinical Utility

Secondary outcome measures

Patient Compliance

PR-0410 Trial Design

1Treatment groups

Experimental Treatment

Group I: Single Arm StudyExperimental Treatment1 Intervention

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

EsoGuard

2020

N/A

~150

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Lucid Diagnostics, Inc.Lead Sponsor

5 Previous Clinical Trials

1,227 Total Patients Enrolled

Gisella LopezStudy DirectorLucid Diagnostics

2 Previous Clinical Trials

540 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this study still open to participants?

"According to clinicaltrials.gov, this research endeavour is continually searching for participants and was initially published on February 23rd 2023, recently updated on September 6th 2023."

Answered by AI

How many health care institutions are currently hosting this experiment?

"This research is being conducted at Arvada West Family Medicine in Arvada, Colorado; Colorado Primary Healthcare in Littleton, Georgia; and Savii Health in Savannah, Texas. Additionally, there are 8 additional medical sites participating."

Answered by AI

What criteria do individuals have to meet in order to be considered for enrollment in this trial?

"This medical experiment requires 500 participants of any gender, aged between 12 and 99 years old who have been diagnosed with barrett's esophagus."

Answered by AI

Is the cut-off age for this trial younger than fifty years of age?

"This clinical trial's qualifications require participants to be between 12 and 99 years old. For patients younger than 18, there are three seperate trials available; for those over 65, a total of 50 spots are open."

Answered by AI

To what extent is this research examining the efficacy of a treatment?

"Affirmative. The information on clinicaltrials.gov indicates that this research project, which was first unveiled on February 23rd 2023 is actively recruiting participants. In total 500 individuals must be recruited from 8 different medical centres."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

CLUE: CLinical Utility Study of EsoGuard

2023. "CLUE: CLinical Utility Study of EsoGuard". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06030180.